Letter to Editor
BibTex RIS Cite

Year 2022, Volume: 85 Issue: 4, 585 - 586, 28.10.2022

Pathum Sookaromdee Viroj Wiwanitkit

https://doi.org/10.26650/IUITFD.1133431

Abstract

References

  • 1. Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020;10:8-9. google scholar
  • 2. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021;20(1):23-44. [CrossRef] google scholar
  • 3. Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 Vaccine booster: to boost or not to boost. Infect Dis Rep 2021;13(4):924-929. [CrossRef] google scholar
  • 4. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021;398(10308):1377-80. [CrossRef] google scholar
  • 5. Mahase E. COVID-19: third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021;373:n1659. [CrossRef] google scholar
  • 6. Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med 2022;10(2):e19. [CrossRef] google scholar
  • 7. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 2022;106(5):e262-3. [CrossRef] google scholar
  • 8. Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med 2022;11(9):2565. [CrossRef] google scholar
  • 9. Sookaromdee P, Wiwanitkit V. New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis. Arch Med Res 2021;52(4):453. [CrossRef] google scholar
  • 10. Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol 2022;14(1):1-3. google scholar

THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS

Year 2022, Volume: 85 Issue: 4, 585 - 586, 28.10.2022

Pathum Sookaromdee Viroj Wiwanitkit

https://doi.org/10.26650/IUITFD.1133431

Abstract

Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients

Keywords

covid vaccine renal transplant dose

References

  • 1. Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020;10:8-9. google scholar
  • 2. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021;20(1):23-44. [CrossRef] google scholar
  • 3. Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 Vaccine booster: to boost or not to boost. Infect Dis Rep 2021;13(4):924-929. [CrossRef] google scholar
  • 4. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021;398(10308):1377-80. [CrossRef] google scholar
  • 5. Mahase E. COVID-19: third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021;373:n1659. [CrossRef] google scholar
  • 6. Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med 2022;10(2):e19. [CrossRef] google scholar
  • 7. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 2022;106(5):e262-3. [CrossRef] google scholar
  • 8. Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med 2022;11(9):2565. [CrossRef] google scholar
  • 9. Sookaromdee P, Wiwanitkit V. New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis. Arch Med Res 2021;52(4):453. [CrossRef] google scholar
  • 10. Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol 2022;14(1):1-3. google scholar
There are 10 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Letter
Authors

Pathum Sookaromdee 0000-0002-8859-5322

Viroj Wiwanitkit 0000-0003-1039-3728

Publication Date October 28, 2022
Submission Date June 20, 2022
Published in Issue Year 2022 Volume: 85 Issue: 4

Cite

APA Sookaromdee, P., & Wiwanitkit, V. (2022). THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. Journal of Istanbul Faculty of Medicine, 85(4), 585-586. https://doi.org/10.26650/IUITFD.1133431
AMA Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İst Tıp Fak Derg. October 2022;85(4):585-586. doi:10.26650/IUITFD.1133431
Chicago Sookaromdee, Pathum, and Viroj Wiwanitkit. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. Journal of Istanbul Faculty of Medicine 85, no. 4 (October 2022): 585-86. https://doi.org/10.26650/IUITFD.1133431.
EndNote Sookaromdee P, Wiwanitkit V (October 1, 2022) THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. Journal of Istanbul Faculty of Medicine 85 4 585–586.
IEEE P. Sookaromdee and V. Wiwanitkit, “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”, İst Tıp Fak Derg, vol. 85, no. 4, pp. 585–586, 2022, doi: 10.26650/IUITFD.1133431.
ISNAD Sookaromdee, Pathum - Wiwanitkit, Viroj. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. Journal of Istanbul Faculty of Medicine 85/4 (October 2022), 585-586. https://doi.org/10.26650/IUITFD.1133431.
JAMA Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İst Tıp Fak Derg. 2022;85:585–586.
MLA Sookaromdee, Pathum and Viroj Wiwanitkit. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. Journal of Istanbul Faculty of Medicine, vol. 85, no. 4, 2022, pp. 585-6, doi:10.26650/IUITFD.1133431.
Vancouver Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İst Tıp Fak Derg. 2022;85(4):585-6.
 Download Cover Image

Contact information and address

Addressi: İ.Ü. İstanbul Tıp Fakültesi Dekanlığı, Turgut Özal Cad. 34093 Çapa, Fatih, İstanbul, TÜRKİYE

Email: itfdergisi@istanbul.edu.tr

Phone: +90 212 414 21 61